34214709|t|Role of inner mitochondrial protein OPA1 in mitochondrial dysfunction by tobacco smoking and in the pathogenesis of COPD.
34214709|a|BACKGROUND: Chronic lung diseases, such as chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) are linked to several mitochondrial alterations. Cigarette smoke (CS) alters the structure and function of mitochondria. OPA1 is the main inner mitochondrial GTPase responsible for the fusion events. OPA1 undergoes proteolytic cleavage from long to short forms during acute stress and mitophagy. However, the exact role of OPA1 isoforms and related proteins during CS-induced mitophagy and COPD is not clear. METHODS: Lung tissues from non-smokers, smokers, COPD and IPF were used to determine the relative expression of OPA1 and related proteins. Additionally, we used mouse lungs from chronic (6 months) CS exposure to evaluate the status of OPA1. Primary lung fibroblasts from normal and COPD patients and naked mole rat (NMR) lung fibroblasts, human fetal lung fibroblast (HFL1), mouse embryonic fibroblast from wild type (WT), OPA1-/-, MFN1 and MFN2-/- were used to determine the effect of CS on OPA1 isoforms. Various mitochondrial fusion promoters/activators (BGP-15, leflunomide, M1) and fission inhibitor (DRP1) were used to determine their effect on OPA1 status and cigarette smoke extract (CSE)-induced lung epithelial (BEAS2B) cell damage, respectively. Seahorse flux analyzer was used to determine the effect of these compounds in BEAS2B cells with and without CSE exposure. FINDINGS: Short OPA1 isoforms were predominantly detected and significantly increased in COPD subjects. Acute CSE treatment in various cell lines except NMR was found to increase the conversion of long to short OPA1 isoforms. CSE treatment significantly increased mitochondrial stress-related protein SLP2 in all the cells used. OPA1 interacting partners like prohibitins (PHB1 and 2) were also altered depending on the CS exposure. Finally, BGP-15 and leflunomide treatment were able to preserve the long OPA1 isoform in cells treated with CSE. INTERPRETATION/CONCLUSION: The long OPA1 isoform along with SLP2 and prohibitins play a crucial role in CS-induced lung damage, causing mitophagy/mitochondrial dysfunction in COPD, which may be used as a novel therapeutic target in COPD.
34214709	14	27	mitochondrial	Disease	MESH:D028361
34214709	36	40	OPA1	Gene	4976
34214709	44	69	mitochondrial dysfunction	Disease	MESH:D028361
34214709	73	80	tobacco	Species	4097
34214709	116	120	COPD	Disease	MESH:D029424
34214709	134	155	Chronic lung diseases	Disease	MESH:D029424
34214709	165	202	chronic obstructive pulmonary disease	Disease	MESH:D029424
34214709	204	208	COPD	Disease	MESH:D029424
34214709	214	243	idiopathic pulmonary fibrosis	Disease	MESH:D054990
34214709	245	248	IPF	Disease	MESH:D054990
34214709	272	285	mitochondrial	Disease	MESH:D028361
34214709	299	314	Cigarette smoke	Chemical	-
34214709	316	318	CS	Chemical	-
34214709	371	375	OPA1	Gene	4976
34214709	394	407	mitochondrial	Disease	MESH:D028361
34214709	450	454	OPA1	Gene	4976
34214709	573	577	OPA1	Gene	4976
34214709	615	617	CS	Chemical	-
34214709	640	644	COPD	Disease	MESH:D029424
34214709	708	712	COPD	Disease	MESH:D029424
34214709	717	720	IPF	Disease	MESH:D054990
34214709	771	775	OPA1	Gene	4976
34214709	820	825	mouse	Species	10090
34214709	856	858	CS	Chemical	-
34214709	894	898	OPA1	Gene	74143
34214709	941	945	COPD	Disease	MESH:D029424
34214709	946	954	patients	Species	9606
34214709	970	973	rat	Species	10116
34214709	998	1003	human	Species	9606
34214709	1034	1039	mouse	Species	10090
34214709	1082	1086	OPA1	Gene	74143
34214709	1091	1095	MFN1	Gene	67414
34214709	1100	1104	MFN2	Gene	170731
34214709	1145	1147	CS	Chemical	-
34214709	1151	1155	OPA1	Gene	4976
34214709	1174	1187	mitochondrial	Disease	MESH:D028361
34214709	1217	1223	BGP-15	Chemical	MESH:C405586
34214709	1225	1236	leflunomide	Chemical	MESH:D000077339
34214709	1238	1240	M1	Chemical	MESH:C400939
34214709	1265	1269	DRP1	Chemical	-
34214709	1310	1314	OPA1	Gene	4976
34214709	1326	1349	cigarette smoke extract	Chemical	-
34214709	1351	1354	CSE	Chemical	-
34214709	1364	1379	lung epithelial	Disease	MESH:D009375
34214709	1381	1387	BEAS2B	CellLine	CVCL:0168
34214709	1494	1500	BEAS2B	CellLine	CVCL:0168
34214709	1524	1527	CSE	Chemical	-
34214709	1554	1558	OPA1	Gene	4976
34214709	1627	1631	COPD	Disease	MESH:D029424
34214709	1648	1651	CSE	Chemical	-
34214709	1749	1753	OPA1	Gene	4976
34214709	1764	1767	CSE	Chemical	-
34214709	1802	1815	mitochondrial	Disease	MESH:D028361
34214709	1867	1871	OPA1	Gene	4976
34214709	1911	1921	PHB1 and 2	Gene	5245;11331
34214709	1958	1960	CS	Chemical	-
34214709	1980	1986	BGP-15	Chemical	MESH:C405586
34214709	1991	2002	leflunomide	Chemical	MESH:D000077339
34214709	2044	2048	OPA1	Gene	4976
34214709	2079	2082	CSE	Chemical	-
34214709	2120	2124	OPA1	Gene	4976
34214709	2188	2190	CS	Chemical	-
34214709	2199	2210	lung damage	Disease	MESH:D008171
34214709	2230	2255	mitochondrial dysfunction	Disease	MESH:D028361
34214709	2259	2263	COPD	Disease	MESH:D029424
34214709	2316	2320	COPD	Disease	MESH:D029424
34214709	Positive_Correlation	MESH:D000077339	MESH:D028361
34214709	Association	11331	4976
34214709	Association	MESH:C405586	4976
34214709	Association	4976	5245
34214709	Association	MESH:D029424	4976
34214709	Positive_Correlation	MESH:C400939	MESH:D028361
34214709	Association	MESH:D028361	4976
34214709	Association	MESH:D000077339	4976
34214709	Positive_Correlation	MESH:C405586	MESH:D028361

